The rapid diagnostic test transformed malaria case management by putting a confirmatory result in the hands of a community health worker without a microscope. Most of these tests detect a single parasite protein—histidine-rich protein 2 (HRP2)—and that reliance has become their structural vulnerability. Parasites carrying deletions of the pfhrp2 and pfhrp3 genes produce no HRP2, and an HRP2-only test reports them as negative even in a symptomatic, parasitemic patient.
Why this matters operationally
The clinical consequence of a false-negative malaria test is not neutral: a febrile patient is sent home untreated, and the program’s surveillance data understate true incidence. WHO guidance recommends that programs consider changing their diagnostic strategy once the prevalence of pfhrp2/3 deletions causing false-negative results crosses a threshold of roughly 5% among symptomatic cases. Recent regional surveys—in parts of the Horn of Africa and Central Africa among them—have reported deletion frequencies above that level, which is what moves this from an academic concern to a procurement decision.
A test that cannot see the parasite circulating in your district is not a sensitive test for your district.
Alternatives and combinations
- Pf-LDH or pan-LDH tests detect a different, non-deleted target and remain positive against pfhrp2-deleted parasites in most evaluations.
- Combination cassettes that read both HRP2 and an LDH line offer a hedge, flagging the discordant pattern that suggests a deleted parasite.
- Microscopy and molecular confirmation remain the reference where capacity exists, and are essential for the deletion surveys that should precede any switch.
A field-minded recommendation
Programs should not abandon HRP2 tests on rumor, nor cling to them on habit. The defensible path is surveillance-led: monitor for the discordant pattern of negative RDTs in microscopy- or PCR-positive patients, commission a deletion survey when that pattern appears, and pre-qualify an LDH-based or combination test as a contingency before it is needed. The hardware question—which cassette—follows the epidemiological one.